CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 28 enrolled
Drug / intervention
ICANbehavioral
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03648476
NCT03648476N/ACompleted
CompareCT.gov

Intervention to Change Attributions That Are Negative (ICAN): a New Approach to Reducing Anger and Aggression After Brain Injury

Indiana University·interventional·Posted Aug 27, 2018·Updated May 23, 2022

In Brief

A clinical study evaluating ICAN for Trauma, Brain and 4 related conditions. Completed, enrolled 28 participants across 1 site.

Detailed Summary

ICAN is the first treatment to target hostile attributions after TBI, making it a novel anger/ aggression management approach in this population. This is a randomized waitlist control trial. The length of time in the trial is approximately 15 weeks and the intervention is 6 weeks long.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsTrauma, Brain, Brain Injuries, Traumatic Brain Injury, Brain Injuries, Traumatic, Brain, Trauma
CountriesUnited States
CollaboratorsNational Institutes of Health (NIH), Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

Timeline

N/ACompletedFinished
20192020202120222023202420252026
First PostedAug 27, 2018
Enrollment StartNov 2, 2018
Primary CompletionNov 23, 2020
Study CompletionJan 11, 2021
TodayJul 2, 2026
Enrollment to primary: 2.1 yearsPosted 7.8 years ago

Interventions

ICANbehavioral

A 6-week group therapy sessions once a week for 90-120 minutes.